Insights

  • Date

  • Content Type

  • Reset

Blog

Better late than never? What developers of SARS-CoV-2 vaccines in early-to -late-stage development should consider

12.05.21

By Michael Pfleiderer

Unfortunately, as of today the ongoing pandemic is still far from being under control, with close to 3...

Read More

Blog

Wake up the Sleeping Beauty – Transposons in gene therapy: How do they compare to other genome modifying tools?

4.05.21

By Ewa Janosz

Gene therapy is currently a quickly developing field. Except from commonly known viral vectors and genome-editing tools, also...

Read More

Blog

Requests for proposals – Get the best value when asking for services

26.04.21

By Timo Liebig

You need a service provider, but which one suits your needs best? Read here how to efficiently structure...

Read More

Blog

AAV gene therapy development: Immunogenicity and safety aspects

2.03.21

By Eveline Molocea and Jörg Schneider

Adeno-associated virus (AAV) is a dominant gene delivery platform that matured in recent years to the level of...

Read More

Blog

Fit-for-purpose immunogenicity assays: What to consider during assay development and validation?

23.02.21

By Nermina Vejzagic

Unwanted immune responses in the form of anti-drug antibodies (including neutralizing antibodies) can be induced in the presence...

Read More

Blog

Recent progress in xenotransplantation – a new way to fight donor organ shortage

2.02.21

By Masin Abo-Rady and Jörg Schneide

The growing worldwide shortage of donor organs is the biggest challenge for patients suffering from end-stage organ failure...

Read More

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more